Lake Villa, IL, United States of America

Steven Cramer Cullen


Average Co-Inventor Count = 5.5

ph-index = 1


Location History:

  • Lake Villa, FL (US) (2014)
  • Lake Villa, IL (US) (2014 - 2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Revolutionizing Hepatitis C Treatment: The Innovations of Steven Cramer Cullen

Introduction

Steven Cramer Cullen, an esteemed inventor based in Lake Villa, IL, has made significant contributions to the field of pharmaceutical innovation. With a portfolio of five patents, he has focused on creating novel compounds aimed at treating hepatitis C infections and other related conditions. His work reflects a dedication to enhancing therapeutic options in the medical field.

Latest Patents

Cullen's latest patents showcase his scientific ingenuity:

1. **Macrocyclic Hepatitis C Serine Protease Inhibitors** - This invention introduces novel macrocyclic compounds designed to treat hepatitis C infection in individuals requiring such therapy. The invention also encompasses pharmaceutical compositions that integrate these compounds with pharmaceutically acceptable carriers or excipients.

2. **Azaadamantane Formate Ester and Process for Preparing Azaadamantane Derivatives** - This patent describes the compound (4S)-1-azaadamantane-4-yl formate ester and details a process for its preparation. It also involves other derivatives and processes for their synthesis, showcasing a comprehensive approach to azaadamantane chemistry.

Career Highlights

Throughout his career, Cullen has aligned himself with notable companies such as AbbVie Inc. and Enanta Pharmaceuticals, Inc. These affiliations have enabled him to translate his innovative ideas into practical applications in the pharmaceutical industry, underlining his expertise in drug development and chemical engineering.

Collaborations

Steven Cramer Cullen has collaborated with prominent industry professionals including Albert Wayne Kruger and Hui-Ju J Chen. These partnerships have fostered a collaborative environment, enhancing his research and development efforts in creating groundbreaking pharmaceutical solutions.

Conclusion

Steven Cramer Cullen stands out as a dedicated inventor whose work in developing treatments for hepatitis C reflects a profound commitment to improving healthcare. His impressive portfolio of patents and collaborations with esteemed companies and colleagues illustrate the impact of his innovations on the pharmaceutical landscape, further advancing the potential for effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…